Immuno-Oncology clinical network Bristol meeting:

Getting stuck into a post-prandial parade of case conundrums with Dr Barlow for our medical oncology community specialising in Immuno-Oncology⬇️

We covered the two common ones - ocular surface disease and #uveitis...

Combined consecutive bilateral occlusive vasculitis and CMV retinitis in immunosuppression with JAK Inhibitor Since their introduction in 2012, Janus kinase (JAK) inhibitors have transformed the management of autoimmune diseases in both systemic and ophthalmological conditions. However, their expanding use ha...

This report illustrates a case of combined consecutive bilateral occlusive vasculitis and cytomegalovirus (CMV) retinitis during treatment with upadacitinib, a selective Janus kinase (JAK1) inhibitor. A literature review is included.

bit.ly/cjo_JAK-inhi...

#Ophthalmology #Uveitis #JAKInhibitor

Meet Julia Xia, MD — the first-ever uveitis fellow trained at CU! ✨

Now practicing in Oregon, she’s building a uveitis program while performing cataract and glaucoma surgery — expanding access to specialized eye care.

Read more: https://bit.ly/4slrx00

#Ophthalmology #Uveitis

Research featuring Lynn Hassman, MD, PhD in American Academy of Ophthalmology finds weekly adalimumab dosing helped over 50% of patients with noninfectious uveitis achieve treatment success in six months.

Read more: https://bit.ly/4b5KmOs

#Ophthalmology #Uveitis #EyeCare

Check out this interesting case study on TINU in this month’s @collegeoptomuk.bsky.social Acuity Journal #optometry #uveitis #ophthalmology

VKH is a rare autoimmune disease where the immune system attacks pigment cells in the eyes and other organs. Early diagnosis and treatment are critical to protect vision. 👁️
#AutoimmuneDisease #EyeHealth #Uveitis #Telehealth #MedicalEducation #RareDisease

Guess who has cells developing where they shouldn't? (Don't worry it's not serious /s) #endometriosis #uveitis

Brilliant minds in one room 👁️✨

Prof. Justine Smith recently visited #NexusEyecare for a catch-up with Dr Anagha Vaze — sharing insights on complex uveitis cases, research & collaborative care.

Because ongoing learning makes all the difference for our patients. #Uveitis

It’s never Lupus… or is it? 🐺

Last month we had a fantastic #Uveitis NW meeting at RCP Spaces at the Spine, highlighting why collaboration between specialities is vital, taking lessons from House MD about avoiding anchoring & spotting masquerades.

#Ophthalmology #Rheumatology

Researchers from UCL and Moorfields Eye Hospital NHS have made a significant contribution to our understanding of uveitis and recently shared their findings in Nature Communications.

Read about the study here: https://ow.ly/8HOX50YbK62

#Research #Uveitis #MedicalResearch

Dazdotuftide eye drops may offer benefit–risk advantage over steroids in noninfectious uveitis Steroid-free dazdotuftide eye drops may offer a benefit–risk advantage over steroids in noninfectious uveitis. They control inflammation to a lesser degree than steroids but have more favorable…

#MedNews - Steroid-free #dazdotuftide eye drops may offer a benefit–risk advantage over steroids in noninfectious #uveitis.

Full story 👉 buff.ly/QoGhkFu

#EyeSky

Looking forward to our pack of North-West residents and fellows gathering to sharpen our diagnostic senses, as we track down the oculo-systemic manifestations of Lupus next week

#Uveitis #Lupus 🌕🐺

CU Anschutz Ophthalmology had a strong presence at the American Uveitis Society Winter Symposium, with eight podium presentations at this year’s meeting in Park City.

Pictured: Lynn Hassman, MD, PhD, presenting research on treatment-resistant uveitis. 👁️✨

#Uveitis

Acute annular outer retinopathy: initial insights into clinical course variations with multimodal imaging To describe the clinical course and provide initial imaging perspectives in acute annular outer retinopathy (AAOR) by reviewing multimodal imaging (MMI) findings.

This study provides initial imaging perspectives in acute annular outer retinopathy (AAOR) by reviewing multimodal imaging (MMI) findings.

bit.ly/cjo_acute-an...

#Ophthalmology #Uveitis

VivaVision Biotech's FDA Meeting Outcome Paves Way for VVN461HD's Development in Uveitis Treatment VivaVision's innovative drug VVN461HD for uveitis treatment needs only one more clinical trial in the U.S. before its NDA submission, following FDA's positive feedback.

VivaVision Biotech's FDA Meeting Outcome Paves Way for VVN461HD's Development in Uveitis Treatment #China #VivaVision #Wenzhou #Uveitis #VVN461HD

Activation of the cGAS–STING pathway drives #RetinalInflammation in #endotoxin-induced #uveitis, while genetic deletion of #cGAS reduces #vitreous inflammation, vascular leakage, and #microglial activation. @fudan-university.bsky.social

#OpenAccess: doi.org/10.1016/j.ge...

Closing out 2025 with our final big St Pauls #Uveitis clinic

Neither resident doctors' strikes nor vicious flu wave disrupting patient attendance - just one DNA🤠Unbelievable

Thanks to both patients & staff for keeping us adequately sweetened and carbed - snacks were consumed at an impressive rate.

PVRL is a life-threatening neoplasm.

It can be mistaken for non-infectious #uveitis, but this case shows that it can also mimic infectious uveitis.

👉 buff.ly/NimlR7i

#OcularTumors #OncSky

Join us for “Steroids in Inflammatory Eye Disease: Friend or Foe?” and put your questions directly to the experts.

Featuring:
Professor Ann Morgan
Miss Kanchan Bhan (Chair)

📅 17 December 2025
⏰ 4–5pm
💻 Online
🔗 Register via link / QR code

#uveitis #ophthalmology #inflammation #eyecare #scleritis

Que te den los brotes de uveitis en el ojo que no sabes guiñar. #uveitis #autoinmune #uveitisfacts

A selfie of my eyes. The whites of one eye is noticeably red and inflamed, with the pupil smaller than the healthy eye.

An image of my hand with large areas of skin on the fingers and thumb that are cracked, dry and peeling painfully

Between the #Uveitis that isn't leaving, and the mysterious peeling skin on my hands, there has to be SOMETHING going on under the surface! Does anyone know of any #AutoimmuneDisorders or similar that have these as symptoms? I need a starting point to be able to broach this with my GP

IFN-λs suppress autoreactive Th1 & Th17 cell responses, promote #Treg expansion, and regulate NLRP1/NLRP3 signaling to preserve BRB integrity and attenuate #OcularInflammation in experimental #Autoimmune #uveitis. #medsky

#OpenAccess: doi.org/10.1016/j.ge...

She's blind in Left eye.... #uveitis... and on steroids....but she's so sweet.

Had a walk out yesterday, just down to the little plantation woods. First time leaving the house all week due to #Uveitis flare up. The worst I've had in about 10 years.

Managed to trip over 4 times but hey ho 😂

#landscapephotography
#WoodlandPhotography #PhotographyIsArt
@photohour.bsky.social

Did you know #IBD doesn't just affect your gut? #Fatigue #Anemia & eye inflammation #Uveitis are extraintestinal manifestations or #ElMs that often go unnoticed. Early recognition can make a difference.

Watch my latest reel 👇🏼 & join the #EIM webinar Tues, 10/7! bit.ly/CommunityHou...

UNICORNS Uveitis in childhood prospective national cohort study

📢 Childhood Onset Uveitis Info Day (UNICORNS Group) 🦄
📅 Sun 5 Oct 2025 | ⏰ 10:00–16:00 BST
📍 Weston House, Great Ormond St, London + Online
Join for expert talks & support on childhood #uveitis

@lolaeyedoc.bsky.social
Unicorns: www.ucl.ac.uk/population-h...

www.eventbrite.com/e/childhood-...

This study links the cyclic guanosine monophosphate-adenosine monophosphate synthase & stimulator of #Interferon genes pathway to #Retinal #Inflammation, offering new treatment strategies for #Uveitis. @fudan-university.bsky.social #medsky
#OpenAccess:
www.sciencedirect.com/science/arti...

Antiviral therapy reduces high rates of CMV-related anterior uveitis recurrence A study reports that 63% of CMV-associated anterior uveitis recurs within 1 year, but that antiviral therapy can reduce this risk by around 60%.

#MedNews - A study reports that 63% of #CMV-associated anterior #uveitis recurs within 1 year, but that antiviral therapy can reduce this risk by around 60%.

👉 buff.ly/WjpkNOb

#EyeSky #IDSky

Another Win for GLP-1 Agonists? A Possible Reduced Risk of Uveitis Weight-loss drugs may fend off eye condition by reducing inflammation

"It opens the door to new possibilities for preventing vision-threatening disease." -- Sumit Sharma, MD, of the Cole Eye Institute at the @clevelandclinic.bsky.social, on a study linking #GLP-1 receptor agonists with a reduced risk of #uveitis.
www.medpagetoday.com/ophthalmolog...

Figure 2. Uveitis Pathogenesis

#Uveitis is characterized by inflammation of the uvea and primarily affects adults aged 20 to 50 years.

➡️ Learn more about the epidemiology, pathophysiology, diagnosis, and treatment of uveitis in this Review.

ja.ma/41xYhaL